TY - JOUR
T1 - Pathogenicity and virulence of Marburg virus
AU - Abir, Mehedy Hasan
AU - Rahman, Tanjilur
AU - Das, Ayan
AU - Etu, Silvia Naznin
AU - Nafiz, Iqbal Hossain
AU - Rakib, Ahmed
AU - Mitra, Saikat
AU - Emran, Talha Bin
AU - Dhama, Kuldeep
AU - Islam, Ariful
AU - Siyadatpanah, Abolghasem
AU - Mahmud, Shafi
AU - Kim, Bonlgee
AU - Hassan, Mohammad Mahmudul
N1 - Publisher Copyright:
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2022
Y1 - 2022
N2 - Marburg virus (MARV) has been a major concern since 1967, with two major outbreaks occurring in 1998 and 2004. Infection from MARV results in severe hemorrhagic fever, causing organ dysfunction and death. Exposure to fruit bats in caves and mines, and human-to-human transmission had major roles in the amplification of MARV outbreaks in African countries. The high fatality rate of up to 90% demands the broad study of MARV diseases (MVD) that correspond with MARV infection. Since large outbreaks are rare for MARV, clinical investigations are often inadequate for providing the substantial data necessary to determine the treatment of MARV disease. Therefore, an overall review may contribute to minimizing the limitations associated with future medical research and improve the clinical management of MVD. In this review, we sought to analyze and amalgamate significant information regarding MARV disease epidemics, pathophysiology, and management approaches to provide a better understanding of this deadly virus and the associated infection.
AB - Marburg virus (MARV) has been a major concern since 1967, with two major outbreaks occurring in 1998 and 2004. Infection from MARV results in severe hemorrhagic fever, causing organ dysfunction and death. Exposure to fruit bats in caves and mines, and human-to-human transmission had major roles in the amplification of MARV outbreaks in African countries. The high fatality rate of up to 90% demands the broad study of MARV diseases (MVD) that correspond with MARV infection. Since large outbreaks are rare for MARV, clinical investigations are often inadequate for providing the substantial data necessary to determine the treatment of MARV disease. Therefore, an overall review may contribute to minimizing the limitations associated with future medical research and improve the clinical management of MVD. In this review, we sought to analyze and amalgamate significant information regarding MARV disease epidemics, pathophysiology, and management approaches to provide a better understanding of this deadly virus and the associated infection.
KW - cellular tropism
KW - epidemiology
KW - Marburg virus
KW - pathogenicity
KW - transmission dynamics
KW - virulence
UR - http://www.scopus.com/inward/record.url?scp=85127429748&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127429748&partnerID=8YFLogxK
U2 - 10.1080/21505594.2022.2054760
DO - 10.1080/21505594.2022.2054760
M3 - Review article
C2 - 35363588
SN - 2150-5594
VL - 13
SP - 609
EP - 633
JO - Virulence
JF - Virulence
IS - 1
M1 - 2054760
ER -